These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20172734)

  • 1. A concise synthesis of 1,4-dihydro-[1,4]diazepine-5,7-dione, a novel 7-TM receptor ligand core structure with melanocortin receptor agonist activity.
    Szewczyk JR; Laudeman CP; Sammond DM; Villeneuve M; Minick DJ; Grizzle MK; Daniels AJ; Andrews JL; Ignar DM
    Bioorg Med Chem; 2010 Mar; 18(5):1822-33. PubMed ID: 20172734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinatorial synthesis and biological evaluation of peptide-binding GPCR-targeted library.
    Lee JY; Im I; Webb TR; McGrath D; Song MR; Kim YC
    Bioorg Chem; 2009 Jun; 37(3):90-5. PubMed ID: 19467690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 1,4-benzodiazepine-2,5-dione small molecule template results in melanocortin receptor agonists with nanomolar potencies.
    Joseph CG; Wilson KR; Wood MS; Sorenson NB; Phan DV; Xiang Z; Witek RM; Haskell-Luevano C
    J Med Chem; 2008 Mar; 51(5):1423-31. PubMed ID: 18271518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal fatty acylated His-dPhe-Arg-Trp-NH(2) tetrapeptides: influence of fatty acid chain length on potency and selectivity at the mouse melanocortin receptors and human melanocytes.
    Todorovic A; Holder JR; Bauzo RM; Scott JW; Kavanagh R; Abdel-Malek Z; Haskell-Luevano C
    J Med Chem; 2005 May; 48(9):3328-36. PubMed ID: 15857138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serendipitous discovery of a new class of agonists for the melanocortin 1 and 4 receptors and a new class of cyclophanes.
    Conde-Frieboes K; Ankersen M; Breinholt J; Hansen BS; Raun K; Thøgersen H; Wulff BS
    Bioorg Med Chem Lett; 2011 Mar; 21(5):1459-63. PubMed ID: 21277204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel and selective beta-melanocyte-stimulating hormone-derived peptide agonist for melanocortin 4 receptor potently decreased food intake and body weight gain in diet-induced obese rats.
    Hsiung HM; Hertel J; Zhang XY; Smith DP; Smiley DL; Heiman ML; Yang DD; Husain S; Mayer JP; Zhang L; Mo H; Yan LZ
    Endocrinology; 2005 Dec; 146(12):5257-66. PubMed ID: 16166226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo design, synthesis, and pharmacology of alpha-melanocyte stimulating hormone analogues derived from somatostatin by a hybrid approach.
    Han G; Haskell-Luevano C; Kendall L; Bonner G; Hadley ME; Cone RD; Hruby VJ
    J Med Chem; 2004 Mar; 47(6):1514-26. PubMed ID: 14998337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of cyclic peptides with agonist activity at melanocortin receptor-4.
    Odagami T; Tsuda Y; Kogami Y; Kouji H; Okada Y
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3723-6. PubMed ID: 16678415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of privileged structures for selective and potent melanocortin subtype-4 receptor ligands.
    Hong Q; Bakshi RK; Dellureficio J; He S; Ye Z; Dobbelaar PH; Sebhat IK; Guo L; Liu J; Jian T; Tang R; Kalyani RN; Macneil T; Vongs A; Rosenblum CI; Weinberg DH; Peng Q; Tamvakopoulos C; Miller RR; Stearns RA; Cashen D; Martin WJ; Chen AS; Metzger JM; Chen HY; Strack AM; Fong TM; Maclntyre E; Van der Ploeg LH; Wyvratt MJ; Nargund RP
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4483-6. PubMed ID: 20598533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1H-NMR studies on a potent and selective antagonist at human melanocortin receptor 4 (hMC-4R).
    Victoria Silva Elipe M; Mosley RT; Bednarek MA; Arison BH
    Biopolymers; 2003 Apr; 68(4):512-27. PubMed ID: 12666176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutive receptor activity series: endogenous inverse agonists and constitutive receptor activity in the melanocortin system.
    Adan RA
    Trends Pharmacol Sci; 2006 Apr; 27(4):183-6. PubMed ID: 16500715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and structure-activity relationships of novel arylpiperazines as potent and selective agonists of the melanocortin subtype-4 receptor.
    Richardson TI; Ornstein PL; Briner K; Fisher MJ; Backer RT; Biggers CK; Clay MP; Emmerson PJ; Hertel LW; Hsiung HM; Husain S; Kahl SD; Lee JA; Lindstrom TD; Martinelli MJ; Mayer JP; Mullaney JT; O'Brien TP; Pawlak JM; Revell KD; Shah J; Zgombick JM; Herr RJ; Melekhov A; Sampson PB; King CH
    J Med Chem; 2004 Jan; 47(3):744-55. PubMed ID: 14736255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of a novel potent cyclic peptide MC4-ligand by ring-closing metathesis.
    Wels B; Kruijtzer JA; Garner K; Nijenhuis WA; Gispen WH; Adan RA; Liskamp RM
    Bioorg Med Chem; 2005 Jul; 13(13):4221-7. PubMed ID: 15876540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and pharmacological in vitro and in vivo evaluations of novel triazole derivatives as ligands of the ghrelin receptor. 1.
    Demange L; Boeglin D; Moulin A; Mousseaux D; Ryan J; Bergé G; Gagne D; Heitz A; Perrissoud D; Locatelli V; Torsello A; Galleyrand JC; Fehrentz JA; Martinez J
    J Med Chem; 2007 Apr; 50(8):1939-57. PubMed ID: 17375904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4-{(2R)-[3-Aminopropionylamido]-3-(2,4-dichlorophenyl)propionyl}-1-{2-[(2-thienyl)ethylaminomethyl]phenyl}piperazine as a potent and selective melanocortin-4 receptor antagonist--design, synthesis, and characterization.
    Chen C; Pontillo J; Fleck BA; Gao Y; Wen J; Tran JA; Tucci FC; Marinkovic D; Foster AC; Saunders J
    J Med Chem; 2004 Dec; 47(27):6821-30. PubMed ID: 15615531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanocortin ligands: 30 years of structure-activity relationship (SAR) studies.
    Holder JR; Haskell-Luevano C
    Med Res Rev; 2004 May; 24(3):325-56. PubMed ID: 14994367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological characterization of 40 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists and the agouti-related protein (AGRP) antagonist.
    Xiang Z; Litherland SA; Sorensen NB; Proneth B; Wood MS; Shaw AM; Millard WJ; Haskell-Luevano C
    Biochemistry; 2006 Jun; 45(23):7277-88. PubMed ID: 16752916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanocortin 4 receptors interact with antimicrobial frog peptide analogues.
    Do EU; Jo EB; Choi G; Piao LZ; Shin J; Seo MD; Kang SJ; Lee BJ; Kim KH; Kim JB; Kim SI
    Biochem Biophys Res Commun; 2006 May; 343(4):1094-100. PubMed ID: 16579969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of pyrrolidine diastereoisomers as potent functional agonists and antagonists of the human melanocortin-4 receptor.
    Chen C; Jiang W; Tran JA; Tucci FC; Fleck BA; Markison S; Wen J; Madan A; Hoare SR; Foster AC; Marinkovic D; Chen CW; Arellano M; Saunders J
    Bioorg Med Chem Lett; 2008 Jan; 18(1):129-36. PubMed ID: 18032040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.